熱門資訊> 正文

ShockWave Medical 2024年第一季度盈利预览

2024-05-04 05:20

ShockWave Medical(SWAV) 0
強生(JNJ) 0

ShockWave Medical (NASDAQ:SWAV) is scheduled to announce Q1 earnings results on Monday, May 6th, after market close.
The consensus EPS Estimate is $0.93 (-9.7% Y/Y) and the consensus Revenue Estimate is $207.65M (+29.0% Y/Y).
Over the last 2 years, SWAV has beaten EPS estimates 63% of the time and has beaten revenue estimates 88% of the time.
Over the last 3 months, EPS estimates have seen 3 upward revisions and 2 downward. Revenue estimates have seen 5 upward revisions and 1 downward.

More on ShockWave Medical

Why Shockwave Medical Stands Out In The Medical Device Sector
Shockwave Medical Q4 Earnings Recap: Plenty Of Reasons To Stay Bullish
Shockwave Medical: Opening Arteries, Delivering Returns
Johnson & Johnson to acquire Shockwave Medical for $13.1B (update)
J&J-Shockwave deal makes strategic sense: analysts

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。